This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gigliotti, F. Articles by Harmsen, A. G. Search for Related Content PubMed PubMed Citation Articles by Gigliotti, F. Articles by Harmsen, A. G.

 Previous Article  |  Next Article 

Infect. Immun., Jun 1996, 1892-1899, Vol 64, No. 6
Copyright © 1996, American Society for Microbiology

Antibody-mediated shift in the profile of glycoprotein A phenotypes observed in a mouse model of Pneumocystis carinii pneumonia

F Gigliotti, BA Garvy and AG Harmsen
Department of Pediatrics, University of Rochester School of Medicine, New York 14642, USA.

It is well established that Pneumocystis carinii has the molecular capability for variation of a major surface antigen, glycoprotein A (gpA). However, the extent of expression of gpA variation among P. carinii organisms infecting a single host and whether this variation has any impact on host-parasite immunological interactions is unknown. Using a mouse model of P. carinii pneumonia, we were able to demonstrate the expression of more than one gpA phenotype in a closed population of infected mice. Administration of monoclonal antibody (MAb) 2B5, which is specific for one of the gpA phenotypes, resulted in a marked diminution in the frequency of this particular gpA phenotype in the population of organisms. This effect was due to a loss of trophozoites bearing the specific epitope recognized by MAb 2B5; cysts bearing the same epitope appeared unaffected. Interestingly, P. carinii was unable to introduce a new phenotype into the population to compensate for the loss of trophozoites bearing the epitope recognized by MAb 2B5. Discontinuing administration of MAb 2B5 allowed the MAb 2B5- binding phenotype to reemerge. This finding suggests that the phenotype recognized by MAb 2B5 was continually produced even when MAb 2B5 was present. Thus, although P. carinii exhibited a form of antigenic variation, it did not appear able to rapidly introduce new phenotypes into the population in response to destruction by antibodies.

This article has been cited by other articles:

• Daly, K. R., Koch, J. V., Shire, N. J., Levin, L., Walzer, P. D. (2006). Human Immunodeficiency Virus-Infected Patients with Prior Pneumocystis Pneumonia Exhibit Increased Serologic Reactivity to Several Major Surface Glycoprotein Clones. CVI 13: 1071-1078 [Abstract] [Full Text]  
• Feola, D. J., Garvy, B. A. (2006). Combination Exposure to Zidovudine plus Sulfamethoxazole-Trimethoprim Diminishes B-Lymphocyte Immune Responses to Pneumocystis murina Infection in Healthy Mice. CVI 13: 193-201 [Abstract] [Full Text]  
• Empey, K. M., Hollifield, M., Schuer, K., Gigliotti, F., Garvy, B. A. (2004). Passive Immunization of Neonatal Mice against Pneumocystis carinii f. sp. muris Enhances Control of Infection without Stimulating Inflammation. Infect. Immun. 72: 6211-6220 [Abstract] [Full Text]  
• Wells, J., Gigliotti, F., Simpson-Haidaris, P. J., Haidaris, C. G. (2004). Epitope Mapping of a Protective Monoclonal Antibody against Pneumocystis carinii with Shared Reactivity to Streptococcus pneumoniae Surface Antigen PspA. Infect. Immun. 72: 1548-1556 [Abstract] [Full Text]  
• Lund, F. E., Schuer, K., Hollifield, M., Randall, T. D., Garvy, B. A. (2003). Clearance of Pneumocystis carinii in Mice Is Dependent on B Cells But Not on P. carinii-Specific Antibody. J. Immunol. 171: 1423-1430 [Abstract] [Full Text]  
• An, C. L., Gigliotti, F., Harmsen, A. G. (2003). Exposure of Immunocompetent Adult Mice to Pneumocystis carinii f. sp. muris by Cohousing: Growth of P. carinii f. sp. muris and Host Immune Response. Infect. Immun. 71: 2065-2070 [Abstract] [Full Text]  
• Gigliotti, F., Haidaris, C. G., Wright, T. W., Harmsen, A. G. (2002). Passive Intranasal Monoclonal Antibody Prophylaxis against Murine Pneumocystis carinii Pneumonia. Infect. Immun. 70: 1069-1074 [Abstract] [Full Text]  
• Walzer, P. D. (1999). Immunological Features of Pneumocystis carinii Infection in Humans. CVI 6: 149-155 [Full Text]  
• Guadiz, G., Haidaris, C. G., Maine, G. N., Simpson-Haidaris, P. J. (1998). The Carboxyl Terminus of Pneumocystis carinii Glycoprotein A Encodes a Functional Glycosylphosphatidylinositol Signal Sequence. J. Biol. Chem. 273: 26202-26209 [Abstract] [Full Text]  
• Mei, Q., Turner, R. E., Sorial, V., Klivington, D., Angus, C. W., Kovacs, J. A. (1998). Characterization of Major Surface Glycoprotein Genes of Human Pneumocystis carinii and High-Level Expression of a Conserved Region. Infect. Immun. 66: 4268-4273 [Abstract] [Full Text]  
• Gigliotti, F., Wiley, J. A., Harmsen, A. G. (1998). Immunization with Pneumocystis carinii gpA Is Immunogenic but Not Protective in a Mouse Model of P. carinii Pneumonia. Infect. Immun. 66: 3179-3182 [Abstract] [Full Text]  
• Linke, M. J., Sunkin, S. M., Andrews, R. P., Stringer, J. R., Walzer, P. D. (1998). Expression, Structure, and Location of Epitopes of the Major Surface Glycoprotein of Pneumocystis carinii f. sp. carinii. CVI 5: 50-57 [Abstract] [Full Text]  
• Hanano, R., Reifenberg, K., Kaufmann, S. H. E. (1998). Activated Pulmonary Macrophages Are Insufficient for Resistance against Pneumocystis carinii. Infect. Immun. 66: 305-314 [Abstract] [Full Text]